LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
46 hedge funds and large institutions have $8.66M invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
46
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$312K | |
| 2 | +$37.1K | |
| 3 | +$32K | |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$13K |
| 5 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$6.88K |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$740K | |
| 3 | -$672K | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$532K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$466K |